The adeno-associated virus vector-based gene therapy is indicated for pediatric and adult patients with severe-to-profound hearing loss due to biallelic OTOF gene variants.
The partnership aims to explore the integration of novel drug-delivery methods with future cochlear implant technology.
New over-the-counter hearing aids and smart glasses with advanced audio features were showcased by multiple companies at CES 2026 in Las Vegas.
The audiology and public health researcher will fill the newly created role of vice president of audiology innovation and research.
Priorities include the Stop CMV Act, Ally’s Act, and Medicare physician reimbursement reform.
Findings from the state's mandated program demonstrate a decreased age at first audiology visit and increased detection of mild hearing loss in infants.
Kasey Kaumans is promoted and Robert C. Luckey joins the company to support channel partners and the AV consultant community.
The company highlights progress in its SENS-501 and GJB2-GT clinical programs, recent financing, and a leadership transition.
The updated design aims to improve accessibility for seniors while remaining compliant with child-safety regulations.